Dr. Amiel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6620 Main St
Suite 1325
Houston, TX 77030Phone+1 713-798-4001Fax+1 713-798-1144
Education & Training
- Ben Gurion University of the NegevClass of 1992
Certifications & Licensure
- TX State Medical License 2009 - 2017
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Everolimus (RAD001) For Advanced Renal Cell Carcinoma (RCC) Before Kidney Removal Start of enrollment: 2011 Apr 01
- S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery Start of enrollment: 2011 Apr 01
Publications & Presentations
PubMed
- An Exploration of the Pillars of Leadership in Cancer Education.Thenugaa Rajeswaran, Krista Dawdy, Maria Bishop, Gilad Amiel, Kathleen Heneghan
Journal of Cancer Education. 2024-06-01 - Prevention of Bladder Cancer Recurrence With the Botanical Formula LCS103: A Case Series Study.Yair Maimon, Gilad Amiel, Zoya Cohen, Azik Hoffman, Noah Samuels
Integrative Cancer Therapies. 2024-02-16 - 7 citationsThe Impact of PSMA PET/CT on Modern Prostate Cancer Management and Decision Making-The Urological Perspective.Azik Hoffman, Gilad E Amiel
Cancers. 2023-06-29
Press Mentions
- Trendlines : First in Human Procedure with Vessi Medical's Cryotherapy System for Bladder CancerJuly 14th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: